AMGN signs a pricing deal with the Trump administration, cutting U.S. drug costs, expanding DTC access and securing tariff relief tied to domestic investment.

On Friday, alongside leaders from Bristol Myers Squibb, Gilead Sciences, and Merck, among other leading pharma giants, the ...

President ​Donald Trump and nine major pharmaceutical companies ‌today announced deals that will slash the prices of their ...

Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid program for low-income people, ...

Migraine pain can be debilitating, and can even lead to a trip to the emergency room in search of relief. As Elissa Carpenter reports, new research is offering more treatment options at the ER.

Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid program for low-income people, senior ...

U.S. President Donald Trump and nine major pharmaceutical companies on Friday announced deals that will slash the prices of ...

Nine large pharma companies have reached agreements with the Trump administration to lower certain drug prices in the U.S. | ...

Patients often wait months to see a neurologist. Virtual neurology care is changing that by expanding access, shortening wait ...

Nine pharmaceutical companies including Merck and GSK agreed to lower certain U.S. prices for their medicines in a new round of industry pacts with the Trump administration. The companies agreed to ...

President Donald Trump announced nine of the largest drugmakers in the U.S. and Europe agreed to voluntarily sell their ...

President Donald Trump is expected to announce on ​Friday new agreements aimed at lowering prescription drug prices, the ...